High dose of dexamethasone attenuates docetaxel-induced fluid retention in breast cancer treatment

High dose of dexamethasone attenuates docetaxel-induced fluid retention in breast cancer treatment

Abstract Docetaxel-induced fluid retention (DIFR) cumulatively occurs and is one of the most troublesome adverse effects. This study aimed to determine whether high dose dexamethasone (DEX) could prevent DIFR during breast cancer treatment. Breast cancer patients receiving docetaxel (75 mg/m2)-conta...

Full description

Bibliographic Details
Main Authors:	Yoshitaka Saito, Ryota Kanno, Yoh Takekuma, Takashi Takeshita, Tomohiro Oshino, Mitsuru Sugawara
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-06-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-023-36264-4

Similar Items

Impact of systemic dexamethasone dosage on docetaxel-induced oral mucositis in patients with breast cancer
by: Yoshitaka Saito, et al.
Published: (2023-06-01)

Impact of systemic dexamethasone administration on oral mucositis induced by anthracycline-containing regimens in breast cancer treatment
by: Yoshitaka Saito, et al.
Published: (2022-07-01)

Impact of reducing day 1 dexamethasone dose in anthracycline-containing regimens on acute gastrointestinal symptoms associated with breast cancer treatment
by: Yoshitaka Saito, et al.
Published: (2021-12-01)

Severe Hypertriglyceridemia Induced by Docetaxel: A Novel Case Report
by: Yoshitaka Saito, et al.
Published: (2021-09-01)

Temporary Severe Neutropenia during Administration of Atezolizumab: A Novel Case Report
by: Ryota Kanno, et al.
Published: (2023-05-01)

Pregabalin Attenuates Carboplatin-Induced Akathisia-Like Neuropathy: A Novel Case Report
by: Yoshitaka Saito, et al.
Published: (2021-10-01)

Impact of preexisting proteinuria on the development of regorafenib-induced problematic proteinuria in real-world metastatic colorectal cancer treatment
by: Yoshitaka Saito, et al.
Published: (2024-03-01)

Detection of factors related to treatment reduction in docetaxel and ramucirumab for non-small cell lung cancer treatment
by: Yoshitaka Saito, et al.
Published: (2023-11-01)

Significantly Delayed Development of Polyarthritis with Active Tenosynovitis after Possible Temporary Neutropenic Immune-Related Adverse Events Caused by Atezolizumab Treatment: A Novel Case Report
by: Yoshitaka Saito, et al.
Published: (2024-01-01)

Hypertriglyceridemia Induced by Fluorouracil: A Novel Case Report
by: Yoshitaka Saito, et al.
Published: (2021-03-01)

Alleviation of Abdominal Pain due to Irinotecan-Induced Cholinergic Syndrome Using Loperamide: A Case Report
by: Kazuki Uchiyama, et al.
Published: (2021-06-01)

Serotonin Syndrome Developing Immediately after the Initiation of Low-Dose Methadone Therapy: A Case Report
by: Masayoshi Kumai, et al.
Published: (2020-03-01)

Difference in the Dissolution Behaviors of Tablets Containing Polyvinylpolypyrrolidone (PVPP) Depending on Pharmaceutical Formulation After Storage Under High Temperature and Humid Conditions
by: Yoh Takekuma, et al.
Published: (2016-12-01)

Onset timing and duration of augmented renal clearance in a mixed intensive care unit
by: Ryusei Mikami, et al.
Published: (2023-03-01)

Intracellular Uptake Mechanism of Lutein in Retinal Pigment Epithelial Cells
by: Yuki Sato, et al.
Published: (2013-08-01)

An imaging approach for determining the mechanism of enhancement of intestinal absorption of an L-theanine supplement.
by: Yuki Sato, et al.
Published: (2021-01-01)

Diabetes mellitus degenerates cisplatin-induced nephrotoxicity in short hydration method: a propensity score-matching analysis
by: Yoshitaka Saito, et al.
Published: (2022-12-01)

Phase 1 Study to Evaluate the Safety of Reducing the Prophylactic Dose of Dexamethasone around Docetaxel Infusion in Patients with Prostate and Breast Cancer
by: Rieneke T. Lugtenberg, et al.
Published: (2023-03-01)

Risk factor analysis for cisplatin-induced nephrotoxicity with the short hydration method in diabetic patients
by: Yoshitaka Saito, et al.
Published: (2023-10-01)

Prediction and Implications of Edoxaban-Associated Bleeding in Patients after Critical Illness
by: Ryusei Mikami, et al.
Published: (2023-01-01)

Validation of the usefulness of artificial neural networks for risk prediction of adverse drug reactions used for individual patients in clinical practice.
by: Shungo Imai, et al.
Published: (2020-01-01)

Higher incidence of acute kidney injury in patients treated with piperacillin/tazobactam than in patients treated with cefepime: a single-center retrospective cohort study
by: Shota Kadomura, et al.
Published: (2019-06-01)

Decrease in Mycophenolic Acid Plasma Level by Sacubitril/Valsartan in a Lupus Nephritis Patient: A Case Report
by: Shunsuke Nashimoto, et al.
Published: (2024-02-01)

Immunoregulatory Effects of Elemental Diet and Its Ingredient, Tryptophan, via Activation of the Aryl Hydrocarbon Receptor in Mice
by: Atsuhito Kubota, et al.
Published: (2024-03-01)

Vomiting in docetaxel chemotherapy: which to blame, dose or gene?
by: Jabir, Rafid, et al.
Published: (2014)

Docetaxel-Mediated Uptake and Retention of Gold Nanoparticles in Tumor Cells and in Cancer-Associated Fibroblasts
by: Abdulaziz Alhussan, et al.
Published: (2021-06-01)

Dose reduction of docetaxel avoids the usage of pegfilgrastim in docetaxel plus ramucirumab therapy for recurrent nonsmall cell lung cancer
by: Kosuke Hamai, et al.
Published: (2023-04-01)

Pharmacokinetic analysis of two different docetaxel dose levels in patients with non-small cell lung cancer treated with docetaxel as monotherapy or with concurrent radiotherapy
by: Kristensen Vessela, et al.
Published: (2007-10-01)

Modified dose dexamethasone premedication for paclitaxel use
by: Sharada Mailankody
Published: (2018-01-01)

Maximum tolerated dose and toxicity evaluation of orally administered docetaxel granule in mice
by: Xiaowei Dong, et al.
Published: (2024-06-01)

Successful Treatment of MMP-9-Expressing Angiosarcoma with Low-Dose Docetaxel and Bisphosphonate
by: Masaya Ishibashi, et al.
Published: (2012-01-01)

QOL Evaluation of Nab-Paclitaxel and Docetaxel for Early Breast Cancer
by: Hiromi Okuyama, et al.
Published: (2018-10-01)

Dexamethasone attenuates airway inflammation in mouse models with allergic asthma
by: LIU Fen, HU Runfang, MAO Song, XU Min, SHI Wenjing, CHEN Ling
Published: (2023-03-01)

Docetaxel Enhances the Expression of STING Protein in PC3 Cells, and cGAMP Attenuates this Effect
by: Shaghayegh Salimi, et al.
Published: (2020-11-01)

Effect of Low Doses of Dexamethasone on Experimental Pulmonary Tuberculosis
by: Jacqueline V. Lara-Espinosa, et al.
Published: (2023-06-01)

Retention of Halogenated Solutes on Stationary Phases Containing Heavy Atoms
by: Toshio Miwa, et al.
Published: (2013-05-01)

Attenuation of Skeletal Muscle Atrophy Induced by Dexamethasone in Rats by Teaghrelin Supplementation
by: Cian-Fen Jhuo, et al.
Published: (2023-01-01)

Dexamethasone Attenuates the Expression of MMP-13 in Chondrocytes through MKP-1
by: Tiina Lehtola, et al.
Published: (2022-03-01)

RNA binding by the glucocorticoid receptor attenuates dexamethasone-induced gene activation
by: Nickolaus C. Lammer, et al.
Published: (2023-06-01)

Dexamethasone attenuates interferon-related cytokine hyperresponsiveness in COVID-19 patients
by: Job J. Engel, et al.
Published: (2023-08-01)